According to the Nasdaq website on February 20th, the Nasdaq-listed company ISPIRE (NASDAQ: ISPR) announced its second quarter financial performance ending on December 31, 2023, and submitted its quarterly report on Form 10-Q on February 20, 2024.
In the second quarter of the 2024 fiscal year, the company's revenue increased by 30.7% compared to the same period in 2023, reaching $41.7 million. Specifically, revenue from tobacco vaporization products was $22.1 million, and revenue from cannabis vaporization products was $19.5 million.
Gross profit also increased by 24.1% from $5.1 million in the same period in 2023 to $6.4 million. The gross profit margin decreased from 16.1% in the same period in 2023 to 15.3%.
However, total operating expenses increased by 114% from $4.8 million in the same period in 2023 to $10.3 million, resulting in a net loss of $4 million compared to a net loss of $100,000 in the same period in 2023.
Michael Wang, CEO of ISPIRE, commented that this quarter is crucial for product expansion and business operations. The company has undertaken several strategic initiatives, including obtaining ISO and GMP certifications for their Malaysian factory, and obtaining Pre-Market Tobacco Product Application (PMTA) approval in the United States. With a significant growth trend in sales related to their cannabis vaporizer hardware, they aim to further strengthen their presence in this market and expand their business scope.
Chief Financial Officer Daniel Machock added that in the second quarter of 2024, key growth indicators for Ispire highlighted the rapid expansion of the cannabis e-cigarette hardware business, with overall revenue increasing by 30% to $41.7 million, while cannabis e-cigarette hardware product sales grew by 149% year-on-year to $19.5 million.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
